Get started
Author

Grégoire Braux

Observed names: Braux Gregoire, Braux, G., Braux, Grégoire, G. Braux, Gregoire Braux
ORCID: 0000-0002-1918-0369
Observed ORCID: 0000-0002-1918-0369
OpenAlex ID: A5073763292
Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study
2025 · Dinu Stefan, Paul Lesueur, et al. · Clinical Cancer Research · 21
Mechanical Thrombectomy in Ischemic Stroke With a Medium or Distal Arterial Occlusion
2026 · Frédéric Clarençon, Fouzi Bala, et al. · JAMA · 8
Trigeminal malignant peripheral nerve-sheath tumor: Systematic review, and case report treated by proton-beam therapy
2024 · Mathieu Lozouet, Lesueur Paul, et al. · Neurochirurgie · 3
More fat, less migration: breast density as a predictor of sentinel lymph node non-visualization in breast cancer
2021 · Elske Quak, Grégoire Braux, et al. · EJNMMI Research · 3
PDF
The threefold value of surgery in previously irradiated brain metastases
2026 · Joshua Marchal, Lucas Ybert, et al. · Journal of Neuro-Oncology · 1
PDF
Phase 1/2a study of concomitant radiotherapy with olaparib and temozolomide in unresectable high-grade glioma patients: Final results from the phase 2a step (OLA-TMZ-RTE-01).
2026 · Dinu Stefan, Justine Lequesne, et al. · Journal of Clinical Oncology · 1
Supplementary Figure 1b. from Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study
2025 · Dinu Stefan, Paul Lesueur, et al. · 1
Incidence and Prognosis of Acute Convexity Subarachnoid Hemorrhage in Sporadic Cerebral Amyloid Angiopathy: A Population-Based Study
2025 · Lilou Crinière-Boizet, Marguerite Watrin, et al. · Stroke
PDF
662MO Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide (TMZ) in unresectable high-grade gliomas patients (pts): Results from the phase IIa (OLA-TMZ-RTE-01)
2025 · D. Stefan, J. Lequesne, et al. · Annals of Oncology
Supplementary Table 1 from Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study
2025 · Dinu Stefan, Paul Lesueur, et al.
Supplementary Figure 1a. from Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study
2025 · Dinu Stefan, Paul Lesueur, et al.
Supplementary Figure 1c. from Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study
2025 · Dinu Stefan, Paul Lesueur, et al.
Supplementary Figure 2. from Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study
2025 · Dinu Stefan, Paul Lesueur, et al.
Data from Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study
2025 · Dinu Stefan, Paul Lesueur, et al.
Actualités sur les encéphalopathies vasculaires ischémiques ou hémorragiques du chien
2024 · Guehl, M., Blot, S., et al. · HAL (Le Centre pour la Communication Scientifique Directe)
Dilated jugular venous arch mimicking a medial neck mass – A case report
2021 · Buu Tran Van, Braux Gregoire, et al. · Archives of Otolaryngology & Rhinology
PDF
Performance diagnostique de l'IRM dans les transformations hémorragiques post accidents ischémiques cérébraux (PITHA)
2020 · Grégoire Braux
Works count: 18
Citation count: 38
H-index: 3
I10-index: 1
Year
Topic
Type